Showing results (31-40 of 107) with videos related to

Sort By:
Pageof 11
Journal of Immunogenetics|October 1, 1983
Impaired H-2 expression in B16 melanoma variantsP Nanni, M P Colombo, C De Giovanni, et al.
Farmaco (Societa Chimica Italiana : 1989)|November 1, 1993
Potential antitumor agents. 23.(1) Cytotoxic and differentiating activity of compounds related to hexamethylenebisacetamideA Andreani, M Rambaldi, A Locatelli, et al.
Transplantation Proceedings|June 21, 2005
Toward the definition of immunosuppressive regimens with antitumor activityF Casadio, S Croci, A D'Errico Grigioni, et al.
British Journal of Cancer|April 1, 1993
Uncoupling of growth inhibition and differentiation in dexamethasone-treated human rhabdomyosarcoma cellsC De Giovanni, P L Lollini, R Dolcetti, et al.
Anticancer Research|November 1, 1992
Ly-6A/E gene is widely expressed among transformed nonhematopoietic cells. Autocrine modulation by interferonP L Lollini, L Landuzzi, G Nicoletti, et al.
British Journal of Cancer|September 1, 1992
Control of H-2 expression in transformed nonhaemopoietic cells by autocrine interferonP Nanni, L Landuzzi, G Nicoletti, et al.
Invasion & Metastasis|January 1, 1992
Induction of invasive and experimental metastasis potential in BALB/c 3T3 cells by benzo(a)pyrene transformationA Melchiori, A Colacci, P L Lollini, et al.
European Journal of Cancer (Oxford, England : 1990)|August 31, 2001
An anti-apoptotic role for NGF receptors in human rhabdomyosarcomaA Astolfi, P Nanni, L Landuzzi, et al.
Scandinavian Journal of Immunology|March 1, 1992
TNF impairs in vivo and in vitro natural killer (NK) susceptibility of B16 melanoma cellsG Palmieri, S Morrone, P L Lollini, et al.
Pageof 11